Home β€Ί Stock analysis β€Ί DHCNL

Diversified Healthcare (DHCNL) Stock: Why It's Down Today

Updated Oct 19, 2026, 4:00 PM ET Β· closing price

What changed since yesterday

DHCNL dips 0.4% to $18.08. Closed at $18.08, -0.39% vs the prior close of $18.15. Day range $17.82–$18.11, opened at $18.11.

Last close$18.08-0.39%
Day range17.82–18.11
Open18.11
Volume3.33K
52-week range17.14–18.35
Avg volume (20d)18.71K

DHCNL daily analysis β€” what happened

A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.

Oct 19, 2026 β€” DHCNL dips 0.4% to $18.08
Oct 16, 2026 β€” DHCNL dips 0.4% to $18.15
Oct 15, 2026 β€” DHCNL rises 2.5% to $18.23
Oct 14, 2026 β€” DHCNL dips 0.5% to $17.78 on 3.7x normal volume
Oct 13, 2026 β€” DHCNL jumps 4.1% to $17.87
Oct 12, 2026 β€” DHCNL ends flat (+0.1%) to $17.16

DHCNL bull case vs bear case (from the data)

Bull case
  • Annual revenue grew 2.8% in the latest fiscal year (SEC XBRL).
  • Insiders made 4 open-market purchases in the last 12 months.
Bear case
  • Latest fiscal-year net income: loss of $285.89M.
  • Thin trading (under $2M a day on average) can mean wide bid/ask spreads.

DHCNL latest news & SEC filings

Every SEC filing by or about DHCNL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 21, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-109321

Sep 21, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-109315

Sep 21, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-109312

Sep 14, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001104659-26-107581

Sep 14, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001104659-26-107580

Sep 14, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001104659-26-107579

Aug 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001799456-26-000010

Aug 12, 2026 Β· Form SCHEDULE 13D/A β€” Update to a 13D 5%+ stake disclosure

Update to a 13D 5%+ stake disclosure

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001687639-26-000001

Aug 3, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001075415-26-000030

Aug 3, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001075415-26-000029

Jul 28, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0002012383-26-002473

Things to know before you trade DHCNL

DHCNL market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 19, 202618.1118.1117.8218.083.33K
Oct 16, 202618.0018.2017.9718.1519.37K
Oct 15, 202617.7318.3217.7318.2330.87K
Oct 14, 202617.5618.3517.3717.7842.84K
Oct 13, 202617.2617.8817.2617.878.89K
Oct 12, 202617.1517.2617.1517.163.30K
Oct 2, 202617.2417.8217.1417.1522.38K

About Diversified Healthcare

Diversified Healthcare (DHCNL) is listed on the Nasdaq and classified by the SEC under β€œReal Estate Investment Trusts”. Its business address is in NEWTON, MA. State of incorporation: MD. Fiscal year ends December 31. SEC CIK 1075415.

DHCNL board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Christopher J. BilottoPresident and CEOSep 21, 2026
Alan L. FelderDirectorJun 12, 2026
Phyllis M. HollisDirectorJun 12, 2026
Lisa Harris JonesDirectorJun 12, 2026
Dawn K. NeherDirectorJun 12, 2026
Adam D. PortnoyDirectorSep 21, 2026
Jeffrey P. SomersDirectorJun 12, 2026

Executive officers

NameTitleLatest filing
Christopher J. BilottoPresident and CEOSep 21, 2026
Matthew C. BrownCFO and TreasurerSep 21, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Dec 15, 2025Christopher J. BilottoBuy20,000$4.89
Dec 15, 2025Christopher J. BilottoBuy20,000$4.89
Dec 15, 2025Christopher J. BilottoBuy20,000$4.89
Dec 15, 2025Christopher J. BilottoBuy20,000$4.89

DHCNL financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$1.54B$-285.89M-1.19$-19.62M
Dec 31, 2024$1.50B$-370.25M-1.55$112.22M
Dec 31, 2023$1.41B$-293.57M-1.23$10.48M
Dec 31, 2022$1.28B$-15.77M-0.07$-40.35M
Dec 31, 2021$1.38B$174.51M0.73$-63.32M

Latest balance sheet: total assets $4.24B, total liabilities $2.66B, cash $116.79M (as of Jun 30, 2026).

DHCNL earnings / results-day log

DateFilingClose that day
Aug 3, 20268-K Item 2.02 (results)β€”
May 4, 20268-K Item 2.02 (results)β€”
Feb 23, 20268-K Item 2.02 (results)β€”
Jan 14, 20268-K Item 2.02 (results)β€”
Nov 3, 20258-K Item 2.02 (results)β€”
Aug 4, 20258-K Item 2.02 (results)β€”
May 5, 20258-K Item 2.02 (results)β€”
Feb 25, 20258-K Item 2.02 (results)β€”
Nov 4, 20248-K Item 2.02 (results)β€”
Aug 1, 20248-K Item 2.02 (results)β€”
May 6, 20248-K Item 2.02 (results)β€”
Feb 26, 20248-K Item 2.02 (results)β€”

Related stocks Β· Real Estate Investment Trusts

Welltower (WELL)American Tower (AMT)Prologis (PLD)Realty Income (O)Equinix (EQIX)Crown Castle (CCI)AGNC Investment (AGNC)Ventas (VTR)Digital Realty (DLR)Vivmark Residential (VMRK)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)

More on DHCNL

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.